US FDA Asks For Comments On Reauthorizing OMUFA, A Program Still New To OTC Industry

Agency conducting all-day online meeting on 28 September to discuss proposed first reauthorization of OMUFA program established with its first five-year authorization in 2020 in legislation to overhaul the OTC monograph program.